SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-23-000012
Filing Date
2023-05-02
Accepted
2023-05-02 16:07:33
Documents
75
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20230331.htm   iXBRL 10-Q 1522164
2 EX-31.1 a2023q110-qexhibit311.htm EX-31.1 10830
3 EX-31.2 a2023q110-qexhibit312.htm EX-31.2 10828
4 EX-32.1 a2023q110-qexhibit321.htm EX-32.1 6399
10 GRAPHIC vrtx-20230331_g1.gif GRAPHIC 10340
  Complete submission text file 0000875320-23-000012.txt   7392347

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20230331.xsd EX-101.SCH 38839
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20230331_cal.xml EX-101.CAL 80908
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20230331_def.xml EX-101.DEF 213575
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20230331_lab.xml EX-101.LAB 519830
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20230331_pre.xml EX-101.PRE 366927
69 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20230331_htm.xml XML 1499576
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 23878944
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences